Analyst Research

Report Title Price
Provider: Thomson Reuters Stock Report
$25.00
Provider: Reuters Investment Profile
$20.00
Provider: Wright Reports
$75.00
Provider: GlobalData
$250.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Health Canada approves Atcor Medical Holdings Ltd's SphygmoCor XCEL for sale in Canada


Tuesday, 28 Jan 2014 05:10pm EST 

Atcor Medical Holdings Ltd:Says that its SphygmoCor XCEL system has been approved by Health Canada, allowing the company to sell its new system to Canadian customers. 

Company Quote

0.089
0.0040 +4.71%
24 Oct 2014